Vitrolife AB (publ) (OTCMKTS:VTRLY) Rating Increased to Outperform at Handelsbanken

Posted by on Sep 17th, 2023

Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) was upgraded by analysts at Handelsbanken from a “market perform” rating to an “outperform” rating in a research report issued on Friday, FlyOnTheWall reports.

Vitrolife AB (publ) Price Performance

VTRLY opened at $11.93 on Friday.

About Vitrolife AB (publ)

(Get Free Report)

Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products.

Featured Articles

Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.